Cypre's blog to discuss the latest movements in science.
November 30, 2023: Cypre Founder and CEO, Kolin Hribar, PhD, is interviewed by the Eureka Blog to discuss revolutionizing oncology drug development with translationally relevant 3D tumor models.
Partner with Cypre to generate translational insights using our 3D tumor microenvironment organoid platform. From targeting the tumor or stroma, to modulating the immune system, we’re built for collaboration.
